Evidence map›Paper›PMID 30787533›Full record

ArticleOman journal of ophthalmology

Normal electro-oculography in a young Omani male with genetically confirmed best disease complicated by choroidal neovascularization.

Mohamed Al-Abri, Ahmed Al-Hinai, Sana Al Zuhaibi, Anuradha Ganesh, Alyaqdhan Al Ghafri, Khalid Al-Thihli

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Oman journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mohamed Al-AbriDepartment of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman.
Ahmed Al-HinaiDepartment of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman.
Sana Al ZuhaibiDepartment of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman.
Anuradha GaneshDepartment of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman.
Alyaqdhan Al GhafriOphthalmology Residency Program, Oman Medical Specialty Board, Muscat, Oman.
Khalid Al-ThihliDepartment of Genetics, Sultan Qaboos University Hospital, Muscat, Oman.
Sultan Qaboos University Hospital · OMOman Medical College · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Best vitelliform macular dystrophy (VMD) is an autosomal dominant macular dystrophy caused by heterozygous mutations in the bestrophin1 gene. Patients with this condition typically have an abnormal electrooculogram. We report a case of a 16-year-old male who presented with gradual progressive vision loss in the right eye. Ophthalmic assessment included funduscopy, optical coherence tomography (OCT), fluorescein angiography, electro-oculography, electroretinography, and genetic testing. Visual acuity was 20/500 and 20/20 in the right and left eyes, respectively. Ophthalmoscopy revealed round yellow lesions in both foveae similar to what is typically seen in Best disease. A subretinal hemorrhage surrounding the right foveal lesion was also noted. OCT demonstrated an elevated neurosensory retina with a subretinal lesion in the right macula. Fluorescein angiography of the right eye confirmed the presence of choroidal neovascularization. Genetic analysis of VMD2/BEST1 sequences confirmed the diagnosis of Best disease. However, contrary to what was expected, the patient's electro-oculography was normal. The findings of this case support a small number of previous reports demonstrating cases of Best disease with normal electro-oculography. While an abnormal electro-oculography along with the typical features of Best disease confirms the diagnosis, a normal result may not exclude the diagnosis. Genetic testing is probably the most important test for establishing the diagnosis of Best disease.

Indexed as

Anti-vascular endothelial growth factorbest diseasechoroidal neovascularizationelectrooculographyvitelliform macular dystrophy

Identifiers

PMID30787533
PMCPMC6380146
OpenAlexW2914555387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.